Levofloxacin Stada (Levofloxacin Hemihydrate)

Levofloxacin blocks bacterial DNA gyrase and topoisomerase IV, enzymes required for DNA replication and transcription. Inhibition leads to DNA breaks, halting bacterial growth and causing cell death, which provides a bactericidal effect against a wide range of pathogens.

The prescribed dose of Levofloxacin Stada is determined by the treating physician based on the infection type, severity, patient age, renal function and other clinical factors. Dosage regimens may differ for respiratory, urinary or skin infections.

Safety data for levofloxacin in pregnancy and lactation are limited. It should only be used when clearly needed after a risk‑benefit assessment by the prescriber. Breast‑feeding mothers should discuss potential exposure with their healthcare professional.

To place an enquiry, visit the product page on gnhindia.com, enter the required quantity and submit the request. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Levofloxacin belongs to the fluoroquinolone class, offering broad‑spectrum coverage and once‑daily dosing for many infections. Compared with macrolides or beta‑lactams, it often provides faster bacterial eradication but carries class‑specific risks such as tendon injury and QT prolongation, which must be weighed by the prescriber.

Store Levofloxacin Stada at temperatures below 25 °C, in its original container, protected from moisture and direct sunlight. Keep the product out of reach of children and avoid exposing it to excessive heat or humidity to maintain potency.

Levofloxacin Stada is taken orally with a full glass of water. It may be taken with or without food, but if gastrointestinal upset occurs, it can be taken with a light meal. Swallow tablets whole; do not crush or chew unless instructed by a healthcare professional.

Serious adverse events include tendon rupture or inflammation, QT‑interval prolongation leading to arrhythmias, severe hypersensitivity reactions such as anaphylaxis, and Clostridioides difficile‑associated colitis. Patients should be educated to report sudden joint pain, palpitations, rash or persistent diarrhea promptly.

Levofloxacin Stada is contraindicated in individuals with a known hypersensitivity to levofloxacin or other fluoroquinolones, those with a history of tendon disorders related to fluoroquinolone use, and patients receiving concomitant medications that significantly prolong the QT interval. Caution is also advised for pregnant or lactating women unless absolutely necessary.